TABLE 2.
Effect of the study interventions on endothelial function and hemodynamic measures
| Baseline Placebo | Baseline Cranberry | p | Acute Placebo | Acute Cranberry | p | 4month Placebo | 4month Cranberry | p | Delta Placebo 4month-Baseline | Delta Cranberry 4month-Baseline | p | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RHI | 1.7±0.4 | 1.7±0.4 | 0.95 | 2.0±0.5 | 2.0±0.6 | 0.99 | 1.8±0.6 | 1.7±0.3 | 0.37 | 0.1±0.5 | −0.0±0.3 | 0.32 |
| SBP | 116.8±15.2 | 115.1±14.0 | 0.59 | 117.7±16.8 | 112.9±23.3 | 0.31 | 115.3±16.6 | 109.8±21.6 | 0.23 | −2.9±10.8 | −4.3±23.8 | 0.77 |
| DBP | 71.5±8.6 | 70.2±9.6 | 0.52 | 71.9±10.2 | 69.9±9.8 | 0.40 | 68.8±8.6 | 70.5±8.6 | 0.44 | −2.8±8.0 | 0.5±5.7 | 0.06 |
| PP | 45.7±12.1 | 44.8±11.7 | 0.72 | 45.8±14.0 | 45.6±13.9 | 0.96 | 46.5±12.4 | 42.8±12.7 | 0.23 | −0.2±9.6 | −1.2±8.5 | 0.65 |
| HR | 67.5±9.4 | 66.1±10.9 | 0.53 | 67.3±8.5 | 67.7±9.9 | 0.86 | 66.5±9.3 | 68.6±11.0 | 0.40 | −0.3±7.0 | 3.2±10.0 | 0.09 |
| AI | 18.1±19.8 | 10.7±18.5 | 0.11 | 17.3±24.0 | 11.9±21.4 | 0.33 | 17.9±17.6 | 12.5±19.0 | 0.23 | −0.2±12.1 | 1.8±13.9 | 0.53 |
RHI = reactive hyperemia index, SBP = systolic blood pressure (mmHg), DBP = diastolic blood pressure (mmHg), PP = pulse pressure (mmHG), HR = heart rate (bpm), AI = augmentation index (measured via EndoPAT)